An introduction to the TITE event

Tehran International Tourism Exhibition (TITE) is the largest official event on tourism and hotel management in Iran. Therefore, it is a unique opportunity for tourism-related businesses to introduce their capabilities and services to those who can benefit from them.

The 12th TITE was held on January 12 to January 15, 2019 at Tehran International Exhibition Center. The event, which was sponsored by the Cultural Heritage, Handicrafts and Tourism Organization of Iran, was also attended by AriaMedTour.

AriaMedTour is the fastest-growing and most innovative company in Iran’s booming medical tourism industry. By partaking in the event, the medical facilitation company secured a positive communication with the other national and international businesses in the industry, showcasing its broad range of services.

AriaMedTour’s meetings at the exhibition

AriaMedTour’s booth in the exhibition saw many significant visitors, including Ali Asghar Mounesan, the head of Cultural Heritage, Handcrafts and Tourism Organization and Dr. Wali Teymouri, the tourism deputy of the organization. These officials had meetings with Hadi Shajari and Hossein Yarahmadi, AriaMedTour’s president and head of the company’s Mashhad branch, to discuss the challenges medical tourism in Iran faces and the benefits that medical tourism facilitators can offer.

Three people having a casual meeting at an exhibition in Tehran

Numerous meetings were held at AriaMedTour’s booth at Tehran International Tourism Exhibition, held on January 12 to 15, 2019.

President of AriaMedTour, Hadi Shajari, speaking with two people in a crowd

President of AriaMedTour, Hadi Shajari, speaking with visitors at Tehran International Tourism Exhibition, held on January 12-15, 2019

In addition to Iranian officials, the AriaMedTour team met with representatives from Azerbaijan, Turkey, Kuwait, Pakistan, Iraq, and Afghanistan. Consequently, the parties agreed upon holding meetings in the aforementioned countries to discuss the terms regarding further collaborations.